“What if hed had the Good Stuff? Adams, Prohibition and Political Cannabinoid Science” a New Posting on The Compassion Chronicles

posted in: US Hemp Co 2


Chicago, IL (PRWEB) February 20, 2014

“Roger Adams’ political views aren’t discussed much,” opened Bryan W. Brickner, publisher of The Cannabis Papers: A citizen’s guide to cannabinoids (2011). “That’s not because he wasn’t political; it’s because of the politics in his science.”

Roger Adams (1889-1971) was head of the Department of Chemistry at the University of Illinois (Urbana-Champaign) from 1926-54. He’s credited with the Adams’ catalyst (platinum dioxide), developing local anesthetics, the synthesis of naturally occurring anthraquinones (dyes, papermaking and medicine), and the structure of gossypol (a natural phenol with pro-apoptotic properties). Adams is also credited with the 1940 discovery of the herbal cannabinoid Cannabidiol (CBD).

In a new post on The Compassion Chronicles, “What if he’d had the Good Stuff? Adams, Prohibition and Political Cannabinoid Science,” Brickner discusses Adams’ 1942 Harvey Lecture, Marihuana.

“Adams was not only a famed chemist,” explained Brickner, “he lived the political nature of scientific research by publicly speaking about marihuana in 1942 – five years after it had been federally banned.”

Brickner continued: “Adams discovered CBD from Minnesota wild hemp, which means there wasn’t much (if any) THC in his research material supplied by the government. While writing The Cannabis Papers, we wondered: what if the famed chemist had been given cannabis with THC in it? Would he have found it 24 years earlier than it was?”

“It’s an open question,” Brickner noted, “though illustrative. It shows the cost of keeping ‘the good stuff’ from a chemist like Adams.”

Brickner graduated from the University of Illinois in 1988 and has a 1997 political science doctorate from Purdue University. The Compassion Chronicles is an online destination for news, opinion, resources and networking.







Vida Cannabis Showcases Its Commitment to Research, Security, Quality and Compassion on New Website

posted in: Cannabis Science 0


Ottawa, ON (PRWEB) February 12, 2015

Vida Cannabis Corp. today announced the official launch of its new website vidacannabis.com. Vida’s site serves as an information resource for the growing number of Canadians who are utilizing legal medical cannabis to treat a multitude of ailments.

The site includes a Learning Centre that addresses questions for patients and doctors about the types of conditions that can be treated with cannabis, how cannabis works, who cannabis helps, and the future of cannabis based medicine.

“We want doctors, patients and stakeholders to learn about all aspects of medical cannabis through powerful videos, concise explanations and our downloadable e-booklet,” said Greg Wilson, Vida Cannabis CEO. “Our goal is to engage, educate, inform and then facilitate access for Canadians to receive the best quality medicine. We believe our new website demonstrates the experience, expertise, professionalism and dedication of the entire Vida team.”

The site features HD videos showcasing Vida’s 315,000-square-foot production facility in Stellarton, Nova Scotia, and its industry leading level-10 security protocols that are directed by former RCMP Chief Superintendent Derek Ogden, Vida’s Chief Operating Officer.

Vida’s emphasis on science and research also come into focus on the new site. Dr. Pritesh Kumar, Vida’s Chief Cannabinoid Research Scientist & Quality Assurance Manager, leads the research team. His entire career is focused on understanding the bioactive components of the cannabis plant. Honoured for his research publications and respected for his innovative research design, Dr. Kumar is at the forefront of the quest to bring 21st century cellular level understanding to the medicinal properties of cannabinoids.

On the cultivation side, Vida has brought together five of the most talented growers from Canada’s west-coast. Known as “The Vida 5” the team is led by Head Master Cultivator Stephen Schroeder.

“Vida shares our standards of integrity and compassion. Our new hydroponic facility is a grower’s dream come true,” says Schroeder.

Learn more about the entire Vida team and its mission on vidacannabis.com. Vida can also be found on its social channels on Twitter, Facebook and Youtube.

About Vida Cannabis:

Vida Cannabis Corp. is working to develop uniquely high quality solutions to meet customer needs in the growing global marketplace for legal cannabis-based products. Initial operations are centered in the Canadian market, where the Federal Government has established national guidelines enabling best-in-class producers to acquire commercial production licenses for medicinal purposes. Vida has assembled one of the top management teams in the world, and has extensive access to expertise and resources in the United States, Canada and Europe. Its 315,000-square-foot production facility, located in Stellarton, Nova Scotia, will be one of the largest, most advanced medical marijuana facilities in Canada.

Disclaimer:

This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. (“Vida Cannabis”). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, “intends,” “anticipates,” “believes,” “expects” and “hopes” and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.







More Cannabis Science Press Releases